MicroRNA-21 in gynecological cancers: From molecular pathogenesis to clinical significance
Authors:
- 21 June 2023
- journal article
- review article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 248, 154630
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Upregulation of miR-21 in Cisplatin Resistant Ovarian Cancer via JNK-1/c-Jun PathwayPLOS ONE, 2014
- Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitorsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2014
- miR-21 modulates paclitaxel sensitivity and hypoxia-inducible factor-1α expression in human ovarian cancer cellsOncology Letters, 2013
- microRNA-21 overexpression contributes to cell proliferation by targeting PTEN in endometrioid endometrial cancerOncology Letters, 2012
- MiR-21 is involved in cervical squamous cell tumorigenesis and regulates CCL20Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- Expression of Mir-21 and Mir-143 in Cervical Specimens Ranging from Histologically Normal through to Invasive Cervical CancerPLOS ONE, 2011
- Expression of MMP-3 and TIMP-3 in gastric cancer tissue and its clinical significanceOncology Letters, 2011
- MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN proteinInternational Journal of Molecular Medicine, 2010
- Upregulation of miR-21 by Ras in vivo and its role in tumor growthOncogene, 2010
- MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cellsBiochemical and Biophysical Research Communications, 2009